676 Results

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Stadler
    Stadler
  4. Joseph
    Joseph
  5. Mandelker
    Mandelker
  6. Berger
    Berger
  7. Solit
    Solit
  8. Hudis
    Hudis
  9. Kauff
    Kauff
  10. Kemel
    Kemel

Groups

  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)
  7. Clinical Genetics Service (297)
  8. Surgery (188)
  9. Department of Pathology and Laboratory Medicine (187)
  10. Epidemiology and Biostatistics (185)
  1. "Mark Robson"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (259)
  3. Review (10)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)

More Groups

People
  1. Mark Robson (676)
  2. Kenneth Offit (280)
  3. Zsofia Stadler (116)
  4. Larry Norton (89)
  5. Vijai Joseph (79)
  6. Diana Mandelker (74)

More People

Years
  1. 2025 (2)
  2. 2024 (32)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (18)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (185)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (50)
  6. Oxford University Press (42)

More Publishers

Results (676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRCA reversion mutations mediated by microhomology-mediated end joining (MMEJ) as a mechanism of resistance to PARP inhibitors in ovarian and breast cancer
    Meeting Abstract

    Lukashchuk, N.; Armenia, J.; Tobalina, L.; Carr, T. H.; Milenkova, T.; Liu, Y. L.; Penson, R. T.; Robson, M. E.; Harrington, E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Lacouture, M. E.; Pan, A.; Dranitsaris, G.; Harris, U.; Chandarlapaty, S.; Dang, C. T.; Gajria, D.; Gordon, A.; Iyengar, N. M.; Robson, M. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A breast cancer (BC) risk model incorporating Tyrer-Cuzick version 8 (TCv8) and a polygenic risk score (PRS) for diverse ancestries
    Meeting Abstract

    Hughes, E.; Probst, B.; Pederson, H. J.; Simmons, T.; Morris, B.; Domchek, S. M.; Eng, C.; Gary, M.; Gordon, O.; Klemp, J. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b/2 study of the BET inhibitor ZEN-3694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations
    Meeting Abstract

    Aftimos, P. G.; Oliveira, M.; Punie, K.; Boni, V.; Hamilton, E. P.; Gucalp, A.; Shah, P. D.; de Miguel, M. J.; Sharma, P.; Bauman, L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants
    Journal Article

    Liu, Y. L.; Maio, A.; Kemel, Y.; Salo-Mullen, E. E.; Sheehan, M.; Tejada, P. R.; Trottier, M.; Arnold, A. G.; Fleischut, M. H.; Latham, A.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: A Mendelian randomisation analysis
    Journal Article

    Shu, X.; Zhou, Q.; Sun, X.; Flesaker, M.; Guo, X.; Long, J.; Robson, M. E.; Shu, X. O.; Zheng, W.; Bernstein, J. L.
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • The Optimal Living Program: Integrating exercise into cancer care
    Meeting Abstract

    Rowed, K.; Shen, S.; Corcoran, S.; Clayton, J.; Kelly, B.; Smith, A.; Emerzian, M.; Cruz, C.; Robson, M.; Iyengar, N.
    Medicine and Science in Sports and Exercise (2022)

    Fulltext@MSK | Save
  • Points to consider regarding risk-reducing mastectomy in high-, moderate-, and low-penetrance gene carriers
    Review

    Corso, G.; Robson, M. E.; Sacchini, V.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Interest and utility of MC1R testing for melanoma risk in dermatology patients with a history of nonmelanoma skin cancer
    Journal Article

    Hay, J. L.; Christian, S. N.; Schofield, E.; Hamilton, J. G.; Yang, C.; Hedayati, B.; Sadeghi, K.; Robson, M. E.; Halpern, A.; Zhang, L.; more...
    Journal of Skin Cancer (2022)

    Fulltext@MSK | Save